...as we have stated repeatedly over the past several years, Pfizer conducted this [Trovan (trovafloxacin)] trial with the full knowledge of the Nigerian government and in a responsible way consistent with Nigerian law and Pfizer’s abiding commitment to patient safety...Pfizer is confident that no one associated with the Trovan clinical study—conducted in Kano, Nigeria during a meningitis epidemic in 1996—ever put a patient’s health at risk and that the company acted in the best interests of the children involved in the study, using the best medical knowledge available. Trovan unquestionably saved lives, and Pfizer strongly disagrees with any suggestion that the company conducted its study in an unethical manner.